Clinical trials
Solar-Recur: A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Men with Biochemical Recurrence of Prostate Cancer
Condition
Biochemical Recurrence of Prostate Cancer
ClinicalTrials.gov identifier
Pending
Interventions
Intervention Type: Drug
Intervention Name: Copper Cu64 PSMA I&T
Intervention Description: Intravenous radionuclide used for PET imaging
Curium Protocol Number
CURCu64PSM0002
Phase
Phase III
Trial Status
Not Yet Recruiting
Protocol Title
A Phase 3, Multi-center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Men with Biochemical Recurrence of Prostate Cancer
Purpose
The purpose of this study is to evaluate the safety, biodistribution, and image quality of Copper Cu64 PSMA I&T Injection to detect metastatic prostate cancer in PET imaging.